CORD-19:4a585fb291dc271a0a5888096c4937488a3cc7b7 / 18953-19214
Annnotations
CORD-19-PD-UBERON
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.
CORD-19-PD-HP
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.
CORD-19_Custom_license_subset
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.
CORD-19-Sentences
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.
CORD-19-PD-MONDO
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.
Epistemic_Statements
34 The role of palivizumab has been recommended for the first year of life for high risk infants with significant heart disease or chronic lung disease of prematurity who are below 32 weeks 0 days gestation and require >21% oxygen for the first 28 days of life.